Leptin is an adipocyte secreted hormone involved in regulation of body weight and metabolism in man. Placenta leptin levels correlate positively with birth weight. It is therefore possible that variation in the leptin receptor gene (LEPR) may contribute to obesity and in¯uence birth weight. OBJECTIVE: This study investigates the in¯uence of the leptin receptor gene variant Gln223Arg (A?G, 668), on maternal body mass index (BMI), foetal gestational length and birth weight in a cohort of 455 healthy pregnant women of Asian Indian (India, Bangladesh, Pakistan) and UKaIrish origin. RESULTS: Maternal genotype distributions did not differ from those expected under Hardy ± Weinberg equilibrium conditions in either population of origin. Maternal genotype for the Gln223Arg leptin receptor gene polymorphism showed no signi®cant association with foetal birth weight (adjusted for gestational length) or with maternal BMI during ®rst trimester (adjusted for age) in either population group. CONCLUSION: These results suggest that the Gln223Arg variant in the maternal leptin receptor gene does not explain the association between placental leptin levels and birth weight, and is not associated with variation in maternal BMI in early pregnancy in our sample.
Introduction
Obesity, de®ned as being more than 20% over expected body weight, is inceasingly prevalent today. 1 There are genetic as well as environmental in¯uences on body weight and propensity to gain weight. 2 Genes thought to be involved in the regulation of pathways involving satiety and energy expenditure, include the leptin (OB), and leptin receptor (LEPR) genes. 1 Leptin is part of a complex lipostatic hormonal feedback loop that involves the regulation of body fat stores. It is a circulating protein which is synthesised and secreted by adipocytes, and may affect many organs of the body including liver, pancreas and reproductive system. Mutations in OB have been identi®ed in morbidly obese patients, and have been shown to affect circulating leptin levels and cause earlyonset obesity. 3 Increases in placental leptin levels have been positively correlated with birth weight, 4 and LEPR mRNA has been shown to be increased in the rat uterus during pregnancy. 5 As leptin is involved in the regulation of body mass index (BMI), signalling via the LEPR may play a role in the regulation of maternal body weight during pregnancy and foetal growth. 6 The LEPR has widespread tissue distribution in several isoforms. Four isoforms have been found in humans: a long isoform, and three shorter isoforms generated by alternative splicing from a single gene locus on chromosome 1 p. 7 Mouse studies have shown that a mutation in the LEPR gene of dbadb mice leads to abnormal mRNA splicing, giving abnormal signal transduction, complete leptin resistance and obesity. 8, 9 It was therefore postulated that defects in the LEPR gene might contribute to obesity in humans. 1 A common variant in exon 6 of LEPR, which causes an amino acid change, Gln223Arg (located in the extracellular domain), and has been associated with variation in BMI, fat mass and fat-free mass in middle aged Caucasian males. 10, 11 We investigated the possible association of this sequence variant with foetal birth weight and maternal BMI during early pregnancy.
Methods
A total of 455 healthy pregnant women were genotyped for the LEPR gene variant Gln223Arg (A?G, 668). Our cohort, collected between 1996 ± 1999 at the antenatal clinic at Northwick Park Hospital, comprised two main population groups, UKaIrish (n 282) and South Asian (India, Bangladesh, Pakistan n 173), which were de®ned by shared country of birth for all four grandparents. Population of origin was determined by completion of a questionnaire.
Maternal genomic DNA was prepared from mouthwash buccal cells, as published. 12 The Gln223Arg variant was detected by PCR-restriction fragment length polymorphism (RFLP) analysis. PCR primers to amplify the Gln223Arg variant analysed have been reported. 13 PCR ampli®cation was performed, with an initial denaturation (94 C, 5 min) then 94 C, 30 s, annealing at 60 C, 30 s, extension at 72 C, 30 s for 35 cycles followed by an additional extension (72 C, 5 min) with 1.5 mM MgCl 2 . PCR products were digested with MspI (Promega) to detect the Arg variant, which creates an MspI restriction site and analysed by gel electrophoresis (2.5% agarose gel).
Results and discussion
Gln223Arg genotype distributions and allele frequencies are presented in Table 1 . Genotype distributions did not differ from those expected for samples from populations in Hardy ± Weinberg equilibrium in either population of origin (UKaIrish P 0.51; South Asian P 0.15 10 In our study, the allele frequencies are similar between our population groups (see Table 1 ), although continent of origin differs.
Descriptive variables were adjusted to remove the in¯u-ence of concomitants within each population group (see Table 2 ) using regression analysis and their distribution compared among genotypes using one-way analysis of variance (ANOVA).
In our study the Gln223Arg variant did not show any signi®cant association with maternal BMI in early pregnancy. This is consistent with the lack of association of the Gln223Arg variant with BMI in British white males reported by Gotoda and colleagues.
14 No association was found between the Gln223Arg variant and BMI in females as reported in the Quebec Family Study. 11 In contrast, an association has previously been observed between Gln223Arg and BMI variation in Caucasian male subjects. 10 It has been documented that maternal serum leptin concentrations correlate positively with gestational age, gestational weight gain or maternal BMI, and subsequently placental leptin levels with birth weight in a study of 52 pregnant women from Egypt. 4 Here, maternal genotype variation at the LEPR Gln223Arg variant site showed no signi®cant association with foetal birth weight in either group, although birth weight increased in offspring of mothers with the variant allele in our UKaIrish population. No association was observed with gestational length.
We have shown there is no signi®cant association of the maternal LEPR Gln223Arg variant with maternal BMI, birth 14 While maternal leptin levels have been signi®cantly associated with maternal weight gain, gestational length and birth weight, 4 the maternal LEPR Gln223Arg variant showed no signi®cant associations with any of these in either of our population groups. LEPR Gln223Arg does not appear to modulate maternal body weight and birth weight in our study, and more complex multiple gene investigation may be required to identify gene variants involved in modulating maternal and infant weight. LEPR polymorphism and maternal BMI and birth weight L Rand et al
